Reinout Stoop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Reinout Stoop has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Harrie Weinans
University Medical Center Utrecht, Utrecht, The Netherlands
4 shared publications - Fereshteh Mirahmadi
Department of Oral Cell Biology and Functional Anatomy, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands; Biomechanics section, Department of Mechanical Engineering, KU Leuven, Leuven, Belgium
3 shared publications - Frank Lobbezoo
Department of Orofacial Pain and Jaw Function, Faculty of Odontology Malmo University Malmö Sweden
3 shared publications - Gerrit Harry van Lenthe
KU Leuven
3 shared publications - Jan Harm Koolstra
Department of Oral Cell Biology and Functional Anatomy, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands
3 shared publications - Jessica Snabel
Department of Metabolic Health Research, The Netherlands Organisation for Applied Scientific Research (TNO), 2333 BE Leiden, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 13 May 2022
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (6) , 1-12
Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
Atypical chemokine receptor 3 (ACKR3, formerly CXC chemokine receptor 7) is a G protein-coupled receptor that recruits β-arrestins, but is devoid of functional G protein signaling after receptor stimulation. In preclinical models of liver and lung fibrosis, ACKR3 was previously shown to be upregulated after acute injury in liver sinusoidal and pulmonary capillary endothelial cells, respectively. This upregulation was linked with a pro-regenerative and anti-fibrotic role for ACKR3. A recently described ACKR3-targeting small molecule agonist protected mice from isoproterenol-induced cardiac fibrosis. Here, we aimed to evaluate its protective role in preclinical models of liver and lung fibrosis. After confirming its in vitro pharmacological activity (i.e., ACKR3-mediated β-arrestin recruitment and receptor binding), in vivo administration of this ACKR3 agonist led to increased mouse CXCL12 plasma levels, indicating in vivo interaction of the agonist with ACKR3. Whereas twice daily in vivo administration of the ACKR3 agonist lacked inhibitory effect on bleomycin-induced lung fibrosis, it had a modest, but significant anti-fibrotic effect in the carbon tetrachloride (CCl4)-induced liver fibrosis model. In the latter model, ACKR3 stimulation affected the expression of several fibrosis-related genes and led to reduced collagen content as determined by picro-sirius red staining and hydroxyproline quantification. These data confirm that ACKR3 agonism, at least to some extent, attenuates fibrosis, although this effect is rather modest and heterogeneous across various tissue types. Stimulating ACKR3 alone without intervening in other signaling pathways involved in the multicellular crosstalk leading to fibrosis will, therefore, most likely not be sufficient to deliver a satisfactory clinical outcome.
- 13 May 2022
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (6) , 1-12
Open AccessStimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
Atypical chemokine receptor 3 (ACKR3, formerly CXC chemokine receptor 7) is a G protein-coupled receptor that recruits β-arrestins, but is devoid of functional G protein signaling after receptor stimulation. In preclinical models of liver and lung fibrosis, ACKR3 was previously shown to be upregulated after acute injury in liver sinusoidal and pulmonary capillary endothelial cells, respectively. This upregulation was linked with a pro-regenerative and anti-fibrotic role for ACKR3. A recently described ACKR3-targeting small molecule agonist protected mice from isoproterenol-induced cardiac fibrosis. Here, we aimed to evaluate its protective role in preclinical models of liver and lung fibrosis. After confirming its in vitro pharmacological activity (i.e., ACKR3-mediated β-arrestin recruitment and receptor binding), in vivo administration of this ACKR3 agonist led to increased mouse CXCL12 plasma levels, indicating in vivo interaction of the agonist with ACKR3. Whereas twice daily in vivo administration of the ACKR3 agonist lacked inhibitory effect on bleomycin-induced lung fibrosis, it had a modest, but significant anti-fibrotic effect in the carbon tetrachloride (CCl4)-induced liver fibrosis model. In the latter model, ACKR3 stimulation affected the expression of several fibrosis-related genes and led to reduced collagen content as determined by picro-sirius red staining and hydroxyproline quantification. These data confirm that ACKR3 agonism, at least to some extent, attenuates fibrosis, although this effect is rather modest and heterogeneous across various tissue types. Stimulating ACKR3 alone without intervening in other signaling pathways involved in the multicellular crosstalk leading to fibrosis will, therefore, most likely not be sufficient to deliver a satisfactory clinical outcome.
- Open Access
- 4 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (13) , 4762
Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal Fibroblasts
Fibroblast to myofibroblast differentiation is a key feature of wound-healing in soft tissues, including the vagina. Vaginal fibroblasts maintain the integrity of the vaginal wall tissues, essential to keep pelvic organs in place and avoid pelvic organ prolapse (POP). The micro-environment of vaginal tissues in POP patients is stiffer and has different extracellular matrix (ECM) composition than healthy vaginal tissues. In this study, we employed a series of matrices with known stiffnesses, as well as vaginal ECMs, in combination with vaginal fibroblasts from POP and healthy tissues to investigate how matrix stiffness and composition regulate myofibroblast differentiation in vaginal fibroblasts. Stiffness was positively correlated to production of α-smooth muscle actin (α-SMA). Vaginal ECMs induced myofibroblast differentiation as both α-SMA and collagen gene expressions were increased. This differentiation was more pronounced in cells seeded on POP-ECMs that were stiffer than those derived from healthy tissues and had higher collagen and elastin protein content. We showed that stiffness and ECM content regulate vaginal myofibroblast differentiation. We provide preliminary evidence that vaginal fibroblasts might recognize POP-ECMs as scar tissues that need to be remodeled. This is fundamentally important for tissue repair, and provides a rational basis for POP disease modelling and therapeutic innovations in vaginal reconstruction.
- 4 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (13) , 4762
Open AccessExtracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal Fibroblasts
Fibroblast to myofibroblast differentiation is a key feature of wound-healing in soft tissues, including the vagina. Vaginal fibroblasts maintain the integrity of the vaginal wall tissues, essential to keep pelvic organs in place and avoid pelvic organ prolapse (POP). The micro-environment of vaginal tissues in POP patients is stiffer and has different extracellular matrix (ECM) composition than healthy vaginal tissues. In this study, we employed a series of matrices with known stiffnesses, as well as vaginal ECMs, in combination with vaginal fibroblasts from POP and healthy tissues to investigate how matrix stiffness and composition regulate myofibroblast differentiation in vaginal fibroblasts. Stiffness was positively correlated to production of α-smooth muscle actin (α-SMA). Vaginal ECMs induced myofibroblast differentiation as both α-SMA and collagen gene expressions were increased. This differentiation was more pronounced in cells seeded on POP-ECMs that were stiffer than those derived from healthy tissues and had higher collagen and elastin protein content. We showed that stiffness and ECM content regulate vaginal myofibroblast differentiation. We provide preliminary evidence that vaginal fibroblasts might recognize POP-ECMs as scar tissues that need to be remodeled. This is fundamentally important for tissue repair, and provides a rational basis for POP disease modelling and therapeutic innovations in vaginal reconstruction.
- 1 May 2020
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 28 (5) , 593-602
High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury
- 1 May 2020
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 28 (5) , 593-602
High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury
- Open Access
- 1 January 2019
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 27 (1) , 118-128
Human C-reactive protein aggravates osteoarthritis development in mice on a high-fat diet
- 1 January 2019
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 27 (1) , 118-128
Open AccessHuman C-reactive protein aggravates osteoarthritis development in mice on a high-fat diet
- 1 December 2018
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 26 (12) , 1744-1752
Aging does not change the compressive stiffness of mandibular condylar cartilage in horses
- 1 December 2018
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 26 (12) , 1744-1752
Aging does not change the compressive stiffness of mandibular condylar cartilage in horses
- 1 March 2018
- Published by Elsevier in Archives of Oral Biology
- Vol. 87, 102-109
Mechanical stiffness of TMJ condylar cartilage increases after artificial aging by ribose
- 1 March 2018
- Published by Elsevier in Archives of Oral Biology
- Vol. 87, 102-109
Mechanical stiffness of TMJ condylar cartilage increases after artificial aging by ribose
- 1 January 2018
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 26 (1) , 95-107
Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought
- 1 January 2018
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 26 (1) , 95-107
Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought
- Open Access
- 1 January 2018
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 5 (1) , 83-98.e10
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model
- 1 January 2018
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 5 (1) , 83-98.e10
Open AccessUncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model